June 07, 2013
Scheme of Arrangment by Listed Companies- SEBI Clarifies and Modifies Norms
The Securities Exchange Board of India ("SEBI") had vide circular dated February 4, 2013 ("Feb Circular") prescribed fresh norms, to be complied with by listed companies, while undertaking a scheme of arrangement under sections 391-394 of the Companies Act, 1956 ("Cos Act"). As discussed in our previous hotline on this subject, although the intention behind the norms prescribed under the Feb Circular was fairly noble i.e. protection of public/minority shareholders, it was felt that the norms were onerous and ambiguous and thus could potentially affect the ability of listed companies to undertake M&As or restructuring(s) by way of a scheme of arrangement. Recognizing the concern of the market participants, SEBI vide a recent circular dated May 21, 2013 ("Current Circular") has made an attempt to (a) clarify the scope of the Feb Circular; and (b) dilute some of the stringent requirements prescribed under the Feb Circular. Our previous hotline on this subject can be accessed here.
WHAT DID THE FEB CIRCULAR STATE?
Historically, SEBI had made several efforts to monitor scheme of arrangements undertaken by listed entities. The key efforts in this direction were (a) the introduction of Clause 24(f) in the listing agreement which requires a listed entity to file the scheme of arrangement with the stock exchange at least one month before it is filed before the court for sanction; (b) the introduction of Clause 24(g) in the listing agreement which states that any scheme of arrangement presented before the court should not violate any securities law or stock exchange requirements; (c) the introduction of Clause 24(i) in the listing agreement which requires listed entities to file, along with the scheme of arrangement under Clause 24(f), an auditors certificate stating that the entity has complied with the accounting standard prescribed by the central government and (d) September 3, 2009 circular1 which inter alia specified the requirements for considering application under clause 19(7) of the Securities Contracts (Regulation) Rules, 1957 ("SCRR") seeking relaxation from the strict enforcement of the listing requirements specified under rule 19(2) of the SCRR.
Even with the above legal requirements in place, SEBI has on several occasions raised concerns that listed entities while undertaking scheme of arrangements were making inadequate disclosures, providing exaggerated valuation and undertaking schemes which were to the detriment of the public/minority shareholders. To address this concern, SEBI introduced the Feb Circular that inter alia required listed companies to undertake stringent compliances while undertaking a scheme of arrangement.
The Feb Circular, in addition to the compliances to be undertaken by listed companies to give effect to a scheme of arrangement, also prescribed, the process and conditions for seeking permission of SEBI for listing, (i) equity shares of an unlisted company under a Scheme of Arrangement, (ii) equity shares with differential rights, and (iii) warrants stapled with non-convertible debentures, in each case without having to comply with the initial public offer requirements under Rule 19(2)(b) of SCRR. One of the key requirements introduced by SEBI under the Feb Circular was the obligation on the listed company to place before its audit committee, a valuation report with respect to the scheme of arrangement issued by an independent charted accountant ("Independent Valuation"). The audit committee was thereafter required to consider the Independent Valuation and prepare a report recommending the scheme.
The Feb Circular also prescribed that the scheme should expressly mention that the scheme would be implemented only after the following approvals are obtained-: (a) shareholder's approval through special resolution passed through a postal ballot and e-voting and (b) approval of at least 2/3rd of the public shareholders of the listed company ("Public Shareholder Approval").
WHAT WAS THE CONCERN?
The Feb Circular raised the following key questions and concerns-:
Allaying the fear of the market participants, SEBI vide the Current Circular has responded to some of the concerns discussed above in the following manner-:
It appears that by virtue of the Feb Circular and the Current Circular, SEBI has gone an extra mile to protect the interest of the public/minority shareholders. Although it is debatable whether in principle the scope of the circular should be wide enough to include all schemes of arrangement undertaken by listed companies, nevertheless the clarification in this regard should be welcomed. Further, the dilution of the requirement for Independent Valuation and Public Shareholder Approval has provided some breather to the listed companies proposing to undertake internal/group restructuring.
Having said that, there are certain outstanding concerns/questions which may require further analysis and clarifications from SEBI. For instance, the language in the Feb Circular (para 5.17 to 5.19) is not very clear on whether SEBI would have the powers to examine the scheme after the high court has approved it or SEBI's mandate will only be limited to the question of whether an exemption under rule 19(7) should be granted. If SEBI's mandate is review the scheme after the scheme is sanctioned by the high court, it is unclear whether the sanction of the high court would be subject to the approval by SEBI. Whilst in one of the instances (albeit prior to the Feb Circular), the Bombay High Court had sanctioned the scheme subject to the approval of the stock exchange, it is unclear whether now all scheme of arrangement(s) by listed companies will suffer the same fate2. The norms as it stands currently is still fairly time consuming and onerous and thus could affect M&As and restructuring by listed companies via the scheme of arrangement route.
1 SEBI/CFD/SCRR/01/2009/03/09, September 3, 2009
2 Elpro International Ltd., In re (2008) 86 SCL 47 (Bom.)
The contents of this hotline should not be construed as legal opinion. View detailed disclaimer.